ALKERMES INSPIRATION GRANTS Trademark

Trademark Overview

On Tuesday, August 2, 2016, a trademark application was filed for ALKERMES INSPIRATION GRANTS with the United States Patent and Trademark Office. The USPTO has given the ALKERMES INSPIRATION GRANTS trademark a serial number of 87123872. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 16, 2024. This trademark is owned by Alkermes, Inc.. The ALKERMES INSPIRATION GRANTS trademark is filed in the Insurance & Financial Services category with the following description:

Providing grants to organizations dedicated to patient focused medical research; funding service awards to patient advocacy groups and institutions for the treatment and management of diseases including, but not limited to, addiction and central nervous system disorders
alkermes inspiration grants

General Information

Serial Number87123872
Word MarkALKERMES INSPIRATION GRANTS
Filing DateTuesday, August 2, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 16, 2024
Registration Number5257710
Registration DateTuesday, August 1, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2017

Trademark Statements

Goods and ServicesProviding grants to organizations dedicated to patient focused medical research; funding service awards to patient advocacy groups and institutions for the treatment and management of diseases including, but not limited to, addiction and central nervous system disorders
Disclaimer with Predetermined Text"GRANTS"

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 16, 2024
Primary Code036
First Use Anywhere DateMonday, September 12, 2016
First Use In Commerce DateMonday, September 12, 2016

Trademark Owner History

Party NameAlkermes, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 024511420
Party NameAlkermes, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 024511420
Party NameAlkermes, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 024511420

Trademark Events

Event DateEvent Description
Friday, February 16, 2024CANCELLED SEC. 8 (6-YR)
Monday, August 1, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 1, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, June 29, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 28, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, June 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 27, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, June 16, 2017USE AMENDMENT FILED
Tuesday, June 27, 2017SOU EXTENSION 1 GRANTED
Friday, June 16, 2017SOU EXTENSION 1 FILED
Saturday, June 24, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, June 16, 2017SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, February 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 15, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, November 15, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 15, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, November 15, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, November 14, 2016ASSIGNED TO EXAMINER
Tuesday, September 13, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, September 13, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, August 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 5, 2016NEW APPLICATION ENTERED

Related Keywords

grants inspiration alkermes patient including diseases management treatment limited central disorders system nervous